CD19 and neoplasm: Consistently with transcriptomic analysis, we also observed marked differences in the mRNA levels of BAX, HRK, CDK6, CDK14, and BCL2 between the sgCONT and NOXAKO tumor cells after co-incubated with CD19 CAR T cells (Fig. 3f).